Literature DB >> 1111183

Experimental study on the genesis of cerebral vasospasm.

R P White, A A Hagen, H Morgan, W N Dawson, J T Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1111183     DOI： 10.1161/01.str.6.1.52

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  11 in total

1.  Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability.

Authors:  M Zuccarello; T Sasaki; N F Kassell; M Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Activity of peripheral sympathetic efferent nerves in experimental subarachnoid haemorrhage. Part II: Observations during the "early vasospasm" period.

Authors:  L Fedina; E Pásztor; B Kocsis; Z Berta
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

3.  Cerebral vasospasm associated with intraventricular hemorrhage.

Authors:  Christopher Dull; Michel T Torbey
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate.

Authors:  M Sonobe; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

5.  Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage.

Authors:  D J Boullin; J Mohan; D G Grahame-Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-08       Impact factor: 10.154

6.  Prostaglandin E2, a postulated astrocyte-derived neurovascular coupling agent, constricts rather than dilates parenchymal arterioles.

Authors:  Fabrice Dabertrand; Rachael M Hannah; Jessica M Pearson; David C Hill-Eubanks; Joseph E Brayden; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

7.  Risk factors for acute symptomatic cerebral infarctions after spontaneous supratentorial intra-cerebral hemorrhage.

Authors:  Hung-Chen Wang; Wei-Che Lin; Tzu-Ming Yang; Yu-Jun Lin; Wu-Fu Chen; Nai-Wen Tsai; Wen-Neng Chang; Cheng-Hsien Lu
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

8.  The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.

Authors:  P C Tagari; A H Kaye; P J Teddy; M Schachter; C B Adams; D J Boullin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

Review 9.  Cerebral vasospasm as a complication of aneurysmal subarachnoid hemorrhage: a brief review.

Authors:  A Spallone
Journal:  Ital J Neurol Sci       Date:  1985-03

10.  Anaerobic change of bloody CSF in subarachnoid haemorrhage. Its relation to cerebral vasospasm.

Authors:  S Suzuki; E Sobata; A Ando; T Iwabuchi
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.